Encompass Health Corporation Cash and Restricted Cash
Encompass Health Corporation (EHC) had Cash and Restricted Cash of $133.50 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-07
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $133.50M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $163.40M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $102.90M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $93.70M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $133.50M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $163.40M 10-Q · filed 2026-05-01 |
| 2025-12-31 | $102.90M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $93.70M 10-Q · filed 2025-10-31 |
| 2025-06-30 | $137.40M 10-Q · filed 2026-08-07 |
| 2025-03-31 | $122.80M 10-Q · filed 2026-05-01 |
| 2024-12-31 | $123.10M 10-Q · filed 2026-08-07 |
| 2024-09-30 | $198.90M 10-Q · filed 2025-10-31 |
| 2024-06-30 | $182.10M 10-Q · filed 2025-08-06 |
| 2024-03-31 | $172.70M 10-Q · filed 2025-05-01 |
| 2023-12-31 | $104.20M 10-K · filed 2026-02-26 |
| 2023-09-30 | $141.20M 10-Q · filed 2024-11-01 |
| 2023-06-30 | $154.00M 10-Q · filed 2024-08-06 |
| 2023-03-31 | $119.30M 10-Q · filed 2024-05-02 |
| 2022-12-31 | $53.40M 10-K · filed 2026-02-26 |
| 2022-09-30 | $104.10M 10-Q · filed 2023-11-01 |
| 2022-06-30 | $257.30M 10-Q · filed 2023-08-04 |
| 2022-03-31 | $155.20M 10-Q · filed 2023-05-03 |
| 2021-12-31 | $120.30M 10-K · filed 2025-02-28 |
| 2021-09-30 | $174.90M 10-Q · filed 2022-11-02 |
| 2021-06-30 | $139.80M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $296.30M 10-Q · filed 2022-05-03 |
| 2020-12-31 | $310.90M 10-K · filed 2024-02-28 |
| 2020-09-30 | $528.10M 10-Q · filed 2021-11-02 |
| 2020-06-30 | $490.00M 10-Q · filed 2021-08-03 |
| 2020-03-31 | $177.00M 10-Q · filed 2021-05-04 |
| 2019-12-31 | $159.60M 10-K · filed 2023-02-27 |
| 2019-09-30 | $513.80M 10-Q · filed 2020-11-02 |
| 2019-06-30 | $287.70M 10-Q · filed 2020-07-31 |
| 2019-03-31 | $120.20M 10-Q · filed 2020-05-11 |
| 2018-12-31 | $133.50M 10-K · filed 2022-02-25 |
| 2018-09-30 | $121.00M 10-Q · filed 2019-10-31 |
| 2018-06-30 | $124.80M 10-Q · filed 2019-07-31 |
| 2018-03-31 | $155.80M 10-Q · filed 2019-05-01 |
| 2017-12-31 | $116.80M 10-K · filed 2021-02-26 |
| 2017-09-30 | $138.40M 10-Q · filed 2018-10-31 |
| 2017-06-30 | $144.10M 10-Q · filed 2018-08-02 |
| 2017-03-31 | $126.80M 10-Q · filed 2018-05-02 |
| 2016-12-31 | $101.40M 10-K · filed 2020-02-27 |
| 2015-12-31 | $107.50M 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |